Wanbo Tai - Search Results

Year	Number of Results
2016	5
2017	5
2018	4
2019	5
2020	7
2021	5
2022	3

1

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.

Wan Y, Shang J, Sun S, Tai W, Chen J, Geng Q, He L, Chen Y, Wu J, Shi Z, Zhou Y, Du L, Li F. Wan Y, et al. Among authors: tai w. J Virol. 2020 Feb 14;94(5):e02015-19. doi: 10.1128/JVI.02015-19. Print 2020 Feb 14. J Virol. 2020. PMID: 31826992 Free PMC article.

2

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.

Tai W, Zhang X, Drelich A, Shi J, Hsu JC, Luchsinger L, Hillyer CD, Tseng CK, Jiang S, Du L. Tai W, et al. Cell Res. 2020 Oct;30(10):932-935. doi: 10.1038/s41422-020-0387-5. Epub 2020 Aug 5. Cell Res. 2020. PMID: 32759966 Free PMC article. No abstract available.

3

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.

Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L. Tai W, et al. Cell Mol Immunol. 2020 Jun;17(6):613-620. doi: 10.1038/s41423-020-0400-4. Epub 2020 Mar 19. Cell Mol Immunol. 2020. PMID: 32203189 Free PMC article.

4

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates.

Ye G, Gallant J, Zheng J, Massey C, Shi K, Tai W, Odle A, Vickers M, Shang J, Wan Y, Du L, Aihara H, Perlman S, LeBeau A, Li F. Ye G, et al. Among authors: tai w. Elife. 2021 Aug 2;10:e64815. doi: 10.7554/eLife.64815. Elife. 2021. PMID: 34338634 Free PMC article.

5

Vaccines for the prevention against the threat of MERS-CoV.

Du L, Tai W, Zhou Y, Jiang S. Du L, et al. Among authors: tai w. Expert Rev Vaccines. 2016 Sep;15(9):1123-34. doi: 10.1586/14760584.2016.1167603. Epub 2016 Apr 6. Expert Rev Vaccines. 2016. PMID: 26985862 Free PMC article. Review.

6

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2.

Ye G, Gallant JP, Massey C, Shi K, Tai W, Zheng J, Odle AE, Vickers MA, Shang J, Wan Y, Drelich A, Kempaiah KR, Tat V, Perlman S, Du L, Tseng CT, Aihara H, LeBeau AM, Li F. Ye G, et al. Among authors: tai w. bioRxiv. 2020 Nov 17:2020.11.17.386532. doi: 10.1101/2020.11.17.386532. Preprint. bioRxiv. 2020. PMID: 33236012 Free PMC article.

7

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection.

Geng Q, Tai W, Baxter VK, Shi J, Wan Y, Zhang X, Montgomery SA, Taft-Benz SA, Anderson EJ, Knight AC, Dinnon KH 3rd, Leist SR, Baric RS, Shang J, Hong SW, Drelich A, Tseng CK, Jenkins M, Heise M, Du L, Li F. Geng Q, et al. Among authors: tai w. PLoS Pathog. 2021 Sep 7;17(9):e1009897. doi: 10.1371/journal.ppat.1009897. eCollection 2021 Sep. PLoS Pathog. 2021. PMID: 34492082 Free PMC article.

8

Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.

Cao W, Dong C, Kim S, Hou D, Tai W, Du L, Im W, Zhang XF. Cao W, et al. Among authors: tai w. Biophys J. 2021 Mar 16;120(6):1011-1019. doi: 10.1016/j.bpj.2021.02.007. Epub 2021 Feb 17. Biophys J. 2021. PMID: 33607086 Free PMC article.

9

Advances in mRNA and other vaccines against MERS-CoV.

Tai W, Zhang X, Yang Y, Zhu J, Du L. Tai W, et al. Transl Res. 2022 Apr;242:20-37. doi: 10.1016/j.trsl.2021.11.007. Epub 2021 Nov 19. Transl Res. 2022. PMID: 34801748 Free PMC article. Review.

10

A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage.

Gambino F Jr, Tai W, Voronin D, Zhang Y, Zhang X, Shi J, Wang X, Wang N, Du L, Qiao L. Gambino F Jr, et al. Among authors: tai w. Cell Rep. 2021 May 11;35(6):109107. doi: 10.1016/j.celrep.2021.109107. Cell Rep. 2021. PMID: 33979612 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results